The Putative Fidgetin Like Protein 2 pipeline drugs market research report outlays comprehensive information on the Putative Fidgetin Like Protein 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Putative Fidgetin Like Protein 2 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Dermatology, Central Nervous System, Ophthalmology, and Cardiovascular which include the indications Wounds, Burns, Spinal Cord Injury, Erectile Dysfunction, Ophthalmology, Keratitis, and Myocardial Infarction. It also reviews key players involved in Putative Fidgetin Like Protein 2 targeted therapeutics development with respective active and dormant or discontinued products.
The Putative Fidgetin Like Protein 2 pipeline targets constitutes close to six molecules. Out of which, approximately five molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in and Preclinical stages are and 5 respectively. Similarly, the universities portfolio in Preclinical comprises 1 molecule.
Putative Fidgetin Like Protein 2 overview
Putative Fidgetin Like Protein 2 (FIGNL2) is a member of the AAA (ATPases Associated with diverse cellular Activities) family of ATPases. While its exact function and biological role are not fully characterized, FIGNL2 shares sequence homology with Fidgetin, a microtubule-severing AAA ATPase. The AAA family is known for its involvement in various cellular processes, often functioning as molecular machines that utilize the energy from ATP hydrolysis to exert mechanical force on their substrates. Fidgetin, the closely related counterpart, has been implicated in microtubule severing, a process crucial for cellular functions such as mitosis and intracellular transport.
For a complete picture of Putative Fidgetin Like Protein 2’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.